Front. Vet. Sci.Frontiers in Veterinary ScienceFront. Vet. Sci.2297-1769Frontiers Media S.A.10.3389/fvets.2025.1654802Veterinary ScienceCorrectionCorrection: New diagnostic assays for differential diagnosis between the two distinct lineages of bovine influenza D viruses and human influenza C virusesOkdaFaten A.12*GriffithElizabeth3SakrAhmed4NelsonEric5WebbyRichard1*1Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, United States2Veterinary Division, National Research Center, Cairo, Egypt3Department of Chemical and Therapeutic, St. Jude Children's Research Hospital, Memphis, TN, United States4Department of Business Administration and Management, Dakota State University, Madison, SD, United States5Veterinary & Biomedical Sciences Department, Animal Disease Research and Diagnostic Laboratory, South Dakota State University, Brookings, SD, United States
Edited and reviewed by: Michael Kogut, United States Department of Agriculture, United States
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Correction on New diagnostic assays for differential diagnosis between the two distinct lineages of bovine influenza D viruses and human influenza C viruses by Okda, F., Griffith, E., Sakr, A., Nelson, E., and Webby, R. (2020). Front. Vet. Sci. 7:605704. doi: 10.3389/fvets.2020.605704influenza D virusesinfluenza C virusesdifferential diagnosispeptide ELISAsblocking ELISAdiagnostic assaysection-at-acceptanceVeterinary Infectious Diseases
There was a mistake in Figure 1C, as published. In the published figure, one line was missing. The corrected Figure 1 and its caption appears below.
Specificity of recombinant proteins vs. that for the whole virus at the IDV convalescent stage. (A) Specificity of recombinant proteins vs. that for the whole virus at the IDV convalescent stage. (B) IFA of IDV-infected MDCK cells using positive and negative bovine serum samples and anti-bovine fluorescein isothiocyanate (FITC) including positive convalescent bovine anti-IDV sera showing strong fluorescent staining of virus-infected cells and Negative serum sample showing no specific fluorescent staining. (C) Mapping of the IDV mAb.
In the published article, Supplementary Images 1–5 were omitted. The files have now been published.
The original version of this article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.